Table 1. Experimental design for L. v. alpina clinical survival experiment, Experiment A.

Population (total number frogs) *	Clutch (total number frogs) *	Exposure group †	Total number of frogs	Number of males ‡	Number of females ‡	Number with undetermined gender
Numbers of L. v. alpina frogs from each population and clutch are outlined, including details of blind randomized block design used for allocation of treatment groups (exposed frogs versus sham-exposed negative control frogs).
Eucumbene (99)	A (30)	E	20	7	13	0
		C	10	6	4	0
	B (19)	E	19	10	9	0
		C	0	0	0	0
	C (29)	E	20	10	10	0
		C	9	4	5	0
	D (21)	E	19	11	8	0
		C	2§	0	1	1
Grey Mare (80)	A (14)	E	14	7	6	1
		C	0	0	0	0
	B (26)	E	20	10	10	0
		C	6	3	3	0
	C (29)	E	20	11	9	0
		C	9	6	3	0
	D (11)	E	11	9	2	0
		C	0	0	0	0
Kiandra (100)	A (25)	E	20	9	11	0
		C	5	1	4	0
	B (25)	E	20	12	8	0
		C	5	1	4	0
	C (25)	E	20|	8	10	2
		C	5	3	2	0
	D (25)	E	20	11	9	0
		C	5	1	4	0
Ogilvies (76)	A (19)	E	19	13	6	0
		C	0	0	0	0
	B (40)	E	20	7	13	0
		C	20	6	14	0
	C (17)	E	16	9	7	0
		C	1¶	0	0	1

*Total number of frogs in parentheses for each group. † E represents exposed frogs, C represents control frogs. ^‡Gender as determined by post-mortem coelomic examination. ^§Includes one frog that died pre-exposure and was excluded from data records. ^|This number includes a frog that died of anasarca post-exposure, unrelated to chytridiomycosis, data still included (frog ID: Lva162). ^¶This frog died pre-exposure and was excluded from data records.